Researchers of Sanaria Inc. are feeding mosquitoes human blood contaminated with the parasite Plasmodium falciparum.
Two weeks later after exposure to humans with contaminated blood, the parasites spread into the mosquito's intestines and salivary glands.
Then researchers expose mosquitoes briefly to radiation to weaken parasites.
The weakened parasites will be extracted from the mosquitoes for purification.
Sanaria Founder Stephen Hoffman said the weaken parasites can produce powerful immune reactions that will give humans 90 percent protection from malaria for at least 10 months based on early clinical tests in adults.
Hoffman said the process will turn a mosquito, which has a capacity to produce two doses, into factory of vaccines for malaria.
In spite of all the positive results, he admitted that the vaccine's development still have a long way to go before it gets mass produced and distributed.
He was hoping that once perfected, the vaccine could protect 25 million babies born annually in sub-Saharan Africa.
World Health Organization reported that Malaria kills nearly 2 million people and 75 percent of the casualties are mostly children.
